Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. advanced 4.8% to $229.29 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.2% to 7,408.30 and Dow Jones Industrial Average falling 1.0% to 51,711.65.

The stock's rise snapped a four-day losing streak.

Charles River Laboratories International Inc. closed 3.6% below its 52-week high of $237.86, which the company achieved on July 10th.

The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 3.4% to $291.02, Alnylam Pharmaceuticals Inc. rose 0.7% to $268.74, and Bio-Techne Corp. remained unchanged.

Trading volume totaled 1.1 million, compared to the 50-day average of 888,225.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 23, 2026 16:35 ET (20:35 GMT)